Ross A. Baker

Irritability and anger attacks affect about one-third of patients with major depressive disorder. This study by Fava et al evaluates adjunctive brexpiprazole as a strategy for patients with MDD...

 

Sleep disturbance in major depressive disorder predicts poorer clinical outcomes and is an independent risk factor for suicide. Read the results of this study that evaluated the effects of...

The objective of this study was to investigate the specific effect of adjunctive aripiprazole on sexual functionin patients with major depressive disorder and a history of an inadequate response...

This post hoc analysis of 3 similarly designed randomized, double-blind, placebo-controlled phase 3 studies investigated the efficacy and safety of adjunctive aripiprazole to standard antidepressant therapy (ADT) in patients...

Patients with depression often do not respond to the initial treatment and clinicians must then adjust therapy. The objective of this study was to determine whether switching within or...

The current study assessed the long-term metabolic effects of aripiprazole monotherapy relative to lithium monotherapy for the treatment of bipolar I disorder.

 

A potential treatment option for residual depression is to add a low-dose antipsychotic to an antidepressant regimen. In this article, Fabian and colleagues analyzed data from 3 similarly designed...